Article Text

First-line treatment for canine epilepsy

Statistics from

Dechra Veterinary Products has launched Soliphen, containing the active substance phenobarbital, for the management of canine epilepsy cases.

The company says that, while phenobarbital is well tolerated and effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, in up to 40 per cent of …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.